SCHEMBL2871232

SCHEMBL2871232

CN(C)Cc1ccc(Nc2ccc(N)c3c2C(=O)c2ccccc2C3=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ MAPT P10636 3/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ ADORA2A P29274 3/20 0.47
▸ CSNK1A1 P48729 2/20 0.47
▸ CSNK1D P48730 2/20 0.47
▸ CSNK1G1 Q9HCP0 2/20 0.47
▸ FGR P09769 1/20 0.47
▸ PIM1 P11309 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ DYRK1A Q13627 1/20 0.47
▸ HIPK2 Q9H2X6 1/20 0.47
▸ P2RY4 P51582 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29637824 1.00 MEN1 (0.50) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL10811745 0.89 MEN1 (0.44) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL10940967 0.87 P2RY4 (0.50) MEN1KMT2AMAPK1ADORA2ACSNK1A1
SCHEMBL11540883 0.86 P2RY4 (0.61) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL13717469 0.85 P2RY12 (0.57) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL10809232 0.81 P2RY4 (0.60) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL4704714 0.81 ADORA2A (0.59) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL10812203 0.81 SLC6A4 (0.55) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL30918998 0.81 ADORA2A (0.63) MEN1KMT2AMAPTTDP1MAPK1
SCHEMBL169365 0.81 ADORA2A (0.63) MEN1KMT2AMAPTTDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575540-A1 AGENT FOR DYING KERATIN FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-09-21 — — EP claimed
WO-2004058200-A1 AGENT FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-07-15 — — WO claimed
EP-0525073-B1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA DU PONT (US) 1994-05-25 — — EP claimed
EP-0525073-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. DU PONT (US) 1993-02-03 — — EP claimed
WO-1991015954-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-31 — — WO claimed
US-10589003-B2 Methods for coating surfaces with antimicrobial agents THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-03-17 — — US disclosed
US-10263308-B2 Solar flow battery CORNELL UNIVERSITY (US) 2019-04-16 — — US disclosed
US-20180303977-A1 METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2018-10-25 — — US disclosed
US-10079401-B2 Symmetric redox flow battery containing organic redox active molecule CORNELL UNIVERSITY (US) 2018-09-18 — — US disclosed
US-20180195207-A1 COPOLYMERIZED ARAMID DOPE-DYED YARN AND METHOD FOR PREPARING SAME KOLON INDUSTRIES, INC. (KR) 2018-07-12 — — US disclosed
US-20180195207-A1 COPOLYMERIZED ARAMID DOPE-DYED YARN AND METHOD FOR PREPARING SAME KOLON INDUSTRIES, INC. (KR) 2018-07-12 — — US disclosed
US-20170187059-A1 SYMMETRIC REDOX FLOW BATTERY CONTAINING ORGANIC REDOX ACTIVE MOLECULE CORNELL UNIVERSITY (US) 2017-06-29 — — US disclosed
US-20050197634-A1 Methods for coating and impregnating medical devices with antiseptic compositions BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2005-09-08 — — US disclosed
WO-2004058200-A1 AGENT FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-07-15 — — WO disclosed
US-5385842-A Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria E. I. DU PONT DE NEMOURS AND COMPANY (US) 1995-01-31 — — US disclosed
EP-0525073-B1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA DU PONT (US) 1994-05-25 — — EP disclosed
EP-0525073-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. DU PONT (US) 1993-02-03 — — EP disclosed
WO-1991015954-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-31 — — WO disclosed
US-4676803-A Reactive azo dyestuffs, free from anionic groups and containing a basic group and halogenotriazinyl radical and useful for dyeing cellulose/polyester BAYER AKTIENGESELLSCHAFT (DE) 1987-06-30 — — US disclosed
US-4503224-A FIBER-REACTIVE, COTTON-POLYESTER BLENDS BAYER AKTIENGESELLSCHAFT (DE) 1985-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10589003-B2 Methods for coating surfaces with antimicrobial agents CUTA, CD63, CDC37 MEN1 4111/4885KMT2A 3316/4885MAPT 3347/4885
US-20180303977-A1 METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS CUTA, CD63, CDC37 MEN1 4111/4885KMT2A 3316/4885MAPT 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback